BCYC
$5.07
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenecti...
Recent News
Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Leadership Transitions
Bicycle Therapeutics (NASDAQ:BCYC) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 3, Bicycle Therapeutics announced several key leadership transitions as the company enters a new phase of innovation for its proprietary bicyclic peptide technology. Travis Thompson, who joined the firm in 2018 and previously served as senior vice […]
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
European equities traded in the US as American depositary receipts were lower late Friday morning, d
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
European equities traded in the US as American depositary receipts were tracking slightly lower late
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking higher late Wednesd
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading
European equities traded in the US as American depositary receipts were sharply lower late Thursday